Listed

Editas Medicine, Inc.: Form 10-K for the period ended Dec 31, 2018

Filed with the SEC on Mar 1, 2019 and accepted by EDGAR at Feb 28, 2019, 18:03 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2018-01-01 to 2018-12-31$90.7mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2018-10-01 to 2018-12-31−$26.3mus-gaap:OperatingIncomeLoss
Operating income12 months2018-01-01 to 2018-12-31−$113.7mus-gaap:OperatingIncomeLoss
Net income3 months2018-10-01 to 2018-12-31−$25.1mus-gaap:NetIncomeLoss
Net income12 months2018-01-01 to 2018-12-31−$110.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2018-10-01 to 2018-12-31−$0.52us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2018-01-01 to 2018-12-31−$2.33us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2018-01-01 to 2018-12-31−$45.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2018-01-01 to 2018-12-31$4.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2018-12-31$134.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-12-31$374.8mus-gaap:AssetsCurrent
Total assetsAt period end2018-12-31$420.4mus-gaap:Assets
Current liabilitiesAt period end2018-12-31$35.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-12-31$184.2mus-gaap:Liabilities
Shareholders' equityAt period end2018-12-31$236.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-19-001364. Last ingested by Listed: Nov 6, 2026, 17:42 ET. Listed shows no prices and gives no investment advice.